特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

生体弁の世界市場:医療機器のパイプライン評価

Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 365829
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.27円で換算しております。
生体弁の世界市場:医療機器のパイプライン評価 Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月18日 ページ情報: 英文 128 Pages
概要

当レポートでは、世界の生体弁の市場における、主要なパイプライン製品とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 生体弁の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 生体弁の企業:治験段階別のパイプライン製品
  • 生体弁:治験段階別のパイプライン製品

第5章 生体弁市場:企業・製品の概要

  • Children's Hospital Boston
    • パイプライン製品および進行中の治験の概要
  • Colibri Heart Valve, LLC
  • CorMatrix Cardiovascular, Inc.
  • CryoLife, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic plc
  • Revivicor, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tendyne Medical, Inc.
  • Tissue Regenix Ltd
  • University of California, Irvine
  • University of Cambridge
  • University of Minnesota
  • ValveXchange, Inc. (Inactive)
  • VueKlar Cardiovascular Ltd.

第6章 生体弁市場:昨今の動向 (全24件)

第7章 付録

図表一覧

図表

List of Tables

  • Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development
  • Table 2: Tissue Heart Valves - Pipeline Products by Segment
  • Table 3: Tissue Heart Valves - Pipeline Products by Territory
  • Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
  • Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • Table 6: Tissue Heart Valves - Ongoing Clinical Trials
  • Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development
  • Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development
  • Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status
  • Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description
  • Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview
  • Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
  • Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Expanded Clinical Study of the Tendyne Mitral Valve System
  • Table 15: Tendyne Bioprosthetic Mitral Valve Implantation System - Feasibility Study of the Tendyne Mitral Valve System for Use in Subjects with Mitral Annular Calcification
  • Table 16: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Heart Valve Leaflet - Product Status
  • Table 18: Heart Valve Leaflet - Product Description
  • Table 19: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Pulmonary Valve - Product Status
  • Table 21: Pulmonary Valve - Product Description
  • Table 22: Sutureless Surgical Aortic Valve - Product Status
  • Table 23: Sutureless Surgical Aortic Valve - Product Description
  • Table 24: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 25: CorMatrix Cor TRICUSPID ECM Valve Device - Product Status
  • Table 26: CorMatrix Cor TRICUSPID ECM Valve Device - Product Description
  • Table 27: CorMatrix ECM - Heart Valve Repair - Product Status
  • Table 28: CorMatrix ECM - Heart Valve Repair - Product Description
  • Table 29: CorMatrix ECM - Heart Valve Replacement - Product Status
  • Table 30: CorMatrix ECM - Heart Valve Replacement - Product Description
  • Table 31: Regenerating Tubular Mitral Valve - Product Status
  • Table 32: Regenerating Tubular Mitral Valve - Product Description
  • Table 33: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview
  • Table 34: CorMatrix Cor TRICUSPID ECM Valve Device - CorMatrix Cor TRICUSPID ECM Valve Replacement Safety and Early Feasibility
  • Table 35: CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: Tricuspid Valve Replacement Device - Product Status
  • Table 37: Tricuspid Valve Replacement Device - Product Description
  • Table 38: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: CryoValve SGAV - Product Status
  • Table 40: CryoValve SGAV - Product Description
  • Table 41: Synergraft Xenograft Heart Valve - Product Status
  • Table 42: Synergraft Xenograft Heart Valve - Product Description
  • Table 43: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Cytograft Valve - Product Status
  • Table 45: Cytograft Valve - Product Description
  • Table 46: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Sutureless Aortic Valve Prosthesis - Product Status
  • Table 48: Sutureless Aortic Valve Prosthesis - Product Description
  • Table 49: Sutureless Mitral Valve Prostheses - Product Status
  • Table 50: Sutureless Mitral Valve Prostheses - Product Description
  • Table 51: Sutureless Tricuspid Valve Prostheses - Product Status
  • Table 52: Sutureless Tricuspid Valve Prostheses - Product Description
  • Table 53: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: GLX Aortic Conduit - Product Status
  • Table 55: GLX Aortic Conduit - Product Description
  • Table 56: INTUITY Valve System - Product Status
  • Table 57: INTUITY Valve System - Product Description
  • Table 58: Konect AVC - Product Status
  • Table 59: Konect AVC - Product Description
  • Table 60: Magna EASE Surgical Valve With GLX - Product Status
  • Table 61: Magna EASE Surgical Valve With GLX - Product Description
  • Table 62: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview
  • Table 63: INTUITY Valve System - Impact of SAVR and TAVR on Patient's Activity and Mobility CAPABILITY Study
  • Table 64: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement
  • Table 65: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve
  • Table 66: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients
  • Table 67: Magna EASE Surgical Valve With GLX - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE

List of Figures

  • Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development
  • Figure 2: Tissue Heart Valves - Pipeline Products by Segment
  • Figure 3: Tissue Heart Valves - Pipeline Products by Territory
  • Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path
  • Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date
  • Figure 6: Tissue Heart Valves - Ongoing Clinical Trials
目次
Product Code: GDME0881EPD

GlobalData's Medical Devices sector report, "Tissue Heart Valves - Medical Devices Pipeline Assessment, 2019" provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 7

2 Introduction 8

  • 2.1 Tissue Heart Valves Overview 8

3 Products under Development 9

  • 3.1 Tissue Heart Valves - Pipeline Products by Stage of Development 9
  • 3.2 Tissue Heart Valves - Pipeline Products by Segment 10
  • 3.3 Tissue Heart Valves - Pipeline Products by Territory 11
  • 3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path 12
  • 3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date 13
  • 3.6 Tissue Heart Valves - Ongoing Clinical Trials 14

4 Tissue Heart Valves - Pipeline Products under Development by Companies 15

  • 4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development 15
  • 4.2 Tissue Heart Valves - Pipeline Products by Stage of Development 16

5 Tissue Heart Valves Companies and Product Overview 18

  • 5.1 Abbott Vascular Inc Company Overview 18
    • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Children's Hospital Boston Company Overview 21
    • 5.2.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Colibri Heart Valve LLC Company Overview 22
    • 5.3.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.4 CorMatrix Cardiovascular Inc Company Overview 24
    • 5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.5 CroiValve Ltd Company Overview 29
    • 5.5.1 CroiValve Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.6 CryoLife Inc Company Overview 30
    • 5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.7 Cytograft Tissue Engineering Inc (Inactive) Company Overview 32
    • 5.7.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.8 Daidalos Solutions BV Company Overview 33
    • 5.8.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.9 Edwards Lifesciences Corp Company Overview 36
    • 5.9.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.10 Hancock Jaffe Laboratories Inc Company Overview 42
    • 5.10.1 Hancock Jaffe Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.11 LivaNova PLC Company Overview 44
    • 5.11.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 44
  • 5.12 Medtronic plc Company Overview 49
    • 5.12.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.13 Revivicor Inc Company Overview 51
    • 5.13.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.14 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 52
    • 5.14.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.15 Stellenbosch University Company Overview 53
    • 5.15.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.16 Tissue Regenix Ltd Company Overview 54
    • 5.16.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.17 University of California Irvine Company Overview 56
    • 5.17.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.18 University of Cambridge Company Overview 58
    • 5.18.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.19 University of Minnesota Company Overview 59
    • 5.19.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.20 University of Zurich Company Overview 60
    • 5.20.1 University of Zurich Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.21 Valcare Medical Company Overview 61
    • 5.21.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.22 ValveXchange, Inc. (Inactive) Company Overview 62
    • 5.22.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.23 VueKlar Cardiovascular Ltd (Inactive) Company Overview 65
    • 5.23.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65

6 Tissue Heart Valves- Recent Developments 66

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 66
  • 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 68
  • 6.3 Oct 30, 2019: OmniGuide Holdings hires Giorgio Brusa as VP Global Marketing and Matthew Rice as Managing Director, OmniGuide Surgical Strategic Business Unit 69
  • 6.4 Oct 30, 2019: LivaNova reports third quarter 2019 results 70
  • 6.5 Oct 30, 2019: CryoLife reports third quarter 2019 financial results 71

7 Appendix 125

  • 7.1 Methodology 125
  • 7.2 About GlobalData 128
  • 7.3 Contact Us 128
  • 7.4 Disclaimer 128